Mefar is a pharmaceutical development and contract manufacturing organization for small- and medium-volume parenteral solutions.
Mefar offers full-service pharmaceutical CDMO services.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Mefar serves local and Fortune 500 pharmaceutical companies.
Mefar manufactures small- and medium-volume parenteral solutions in ampoules, pre-filled syringes, vials, and blow-fill-seal containers, and offers lyophilisation.
Source: LinkedIn company description · Retrieved October 13, 2026
Services include solution preparation, aseptic filling, packaging, cold chain management, and serialization.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
Open the published source list.RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 2, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 14, 2026, September 15, 2026, September 16, 2026, September 17, 2026, September 18, 2026, September 21, 2026, September 27, 2026, September 28, 2026, September 29, 2026, October 7, 2026, October 8, 2026, October 9, 2026, October 10, 2026 and October 11, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.